In vitro cytotoxicity, apoptosis, DNA-binding, and antioxidant activity studies of ruthenium (II) complexes

DNA and Cell Biology

Volumn 29, Issue 5, 2010, Pages 261-270

  Huang, Hong Liang ^a   Liu, Yun Jun ^a   Zeng, Cheng Hui ^a   He, Li Xin ^a   Wu, Fu Hai ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; 2 (3 AMINOPHENYL)IMIZADO[4,5 F][1,10]PHENANTHROLINE; 2 (4 AMINOPHENYL)IMIZADO[4,5 F][1,10]PHENANTHROLINE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; [1,10 PHENANTHROLINE 2 (3 AMINOPHENYL)IMIDAZO[4,5 F][1,10]PHENANTHROLINE RUTHENIUM] PERCHLORATE; [1,10 PHENANTHROLINE 2 (4 AMINOPHENYL)IMIDAZO[4,5 F][1,10]PHENANTHROLINE RUTHENIUM] PERCHLORATE; ACRIDINE ORANGE; ETHIDIUM BROMIDE; RUTHENIUM COMPLEX; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DNA CLEAVAGE; DNA DENATURATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; SPECTROSCOPY; STAINING; THERMAL ANALYSIS; VISCOMETRY;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; DNA; HUMANS; INTERCALATING AGENTS; PHENANTHROLINES; RUTHENIUM; VISCOSITY;

EID: 77952388630     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2009.0979     Document Type: Article

References (39)

1. Arockiasamy, D.L., Radhika, S., Parthasarathi, R., and Nair, B.U. (2009). Synthesis and DNA-binding studies of two ruthenium(II) complexes of an intercalating ligand. Eur J Med Chem 44, 2044-2051.
2. Blasius, R., Moucheron, C., and Mesmasker, A.K. (2004). Photoadducts of metallic compounds with nucleic acids-role played by the photoelectron transfer process and by the TAP and HAT ligands in the RuII complexes. Eur J Inorg Chem 20, 3971-3979.
3. Carter, M.T., Rodriguez, M., and Bard, A. (1989). Voltammetric studies of the interaction of metal chelates with DNA. 2. Tris-chelated complexes of cobalt(III) and iron(II) with 1,10-phenanthroline and 2,2'-bipyridine. J Am Chem Soc 111, 8901-8911.
4. Chaires, J.B., Dattagupta, N., and Crothers, D.M. (1982). Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on the interaction of daunomycin with deoxyribonucleic acid. Biochemistry 21, 3933-3940.
5. Chen, H., Parkinson, J.A., Morris, R.E., and Sadler, P.J. (2003). Highly selective binding of organometallic ruthenium ethyle-nediamine complexes to nucleic acids: novel recognition mechanisms. J Am Chem Soc 125, 173-186.
6. Chen, H.L., Liu, H.Q., Tzeng, B.C., You, Y.S., Peng, S.M., Yang, M.S., and Che, C.M. (2002). Syntheses of ruthenium(II) qui-nonediimine complexes of cyclam and characterization of their DNA-binding activities and cytotoxicity. Inorg Chem 41, 3161-3171.
7. 2+ (L=Im and MeIm). J Inorg Biochem 102, 330-341.
8. Cheng, C.C., Rokita, S.E., and Burrows, C.J. (1993). Nickel(III)-promoted DNA cleavage with ambient dioxygen. Angew Chem Int Ed Engl 32, 277-280.
9. Cocchietto, M., and Sava, G. (2000). Blood concentration and toxicity of the antimetastasis agent NAMI-A following repeated intravenous treatment in mice. Pharmacol Toxicol 87, 193-197.
10. Cohen, G., and Eisenberg, H. (1969). Viscosity and sedimentation study of sonicated DNA-proflavine complexes. Biopolymers 8, 45-55.
11. Erkkila, K.E., Odem, D.T., and Barton, J.K. (1999). Recognition and reaction of metallointercalators with DNA. Chem Rev 99, 2777-2796.
12. Gao, F., Chao, H., Wang, J.Q., Yuan, Y.X., Sun, B., Wei, Y.F., Peng, B., and Ji, L.N. (2007). Targeting topoisomerase II with the chiral DNA-intercalating ruthenium(II) polypyridyl complexes. J Biol Inorg Chem 12, 1015-1027.
13. Han, M.J., Gao, L.H., Lü, Y.Y., and Wang, K.Z. (2006). Ruthenium(II) complex of Hbopip: synthesis, characterization, pHinduced luminescence off-on-off switch and avid binding to DNA. J Phys Chem B 110, 2364-2371.
14. Hartinger, C.G., Zorbas-Seifried, S., Jakupec, M.A., Zorbas, H., and Kepper, B.K. (2006). From bench to bedside-preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H- indazole)ruthenate(III)] (KP1019 or FFC14A). J Inorg Biochem 100, 891-904.
15. Hickman, J.A. (1992). Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11, 121-139.
16. Lesko, S.A., Lorentzen, R.J., and Ts'o, P.O. (1980). Role of superoxide in deoxyribonucleic acid strand scission. Biochemistry 19, 3023-3028.
17. Li, T.R., Yang, Z.Y., Wang, B.D., and Qin, D.D. (2008). Synthesis, characterization, antioxidant activity and DNA-binding studies of two rare earth(III) complexes with naringenin-2-hydroxy benzoyl hydrazone ligand. Eur J Med Chem 43, 1688-1695.
18. Liu, J., Zheng, W.J., Shi, S., Tan, C.P., Chen, J.C., Zheng, K.C., and Ji, L.N. (2008). Synthesis, antitumor activity and structure - activity relationships of a series of Ru(II) complexes. J Inorg Biochem 102, 193-202.
19. Liu, Y.J., Zeng, C.H., Wu, F.H., Yao, J.H., He, L.X., and Huang, H.L. (2009). Synthesis, characterization, photocleavage of DNA and cytotoxicity of ruthenium(II) mixed-ligand complexes. J Mol Struc 932, 105-111.
20. Marmur, J. (1961). A procedure for the isolation of deoxy-ribonucleic acid from microorganism. J Mol Biol 3, 2080-2011.
21. McGee, J.D. (1976). Theoretical calculations of the helix-coil transition of DNA in the presence of large, cooperatively binding ligands. Biopolymers 15, 1345-1375.
22. Metcalfe, C., and Thomas, J.A. (2003). Kinetically inert transition metal complexes that reversibly bind to DNA. Chem Soc Rev 32, 215-224.
23. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63.
24. Nilsson, R., Merkel, P.B., and Kearns, D.R. (1972). Unambiguous evidence for the participation of singlet oxygen in photodynamic oxidadtion of amino acids. Photochem Photobiol 16, 117-124.
25. Reichmann, M.F., Rice, S.A., Thomas, C.A., and Doty, P. (1954). A further examination of the molecular weight and size of desoxypentose nucleic acid. J Am Chem Soc 76, 3047-3053.
26. Satyanarayana, S., Dabrowiak, J.C., and Chaires, J.B. (1993). Tri(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding. Biochemistry 32, 2573-2584.
27. 2+(L = o-npip, m-npip and p-npip). Dalton Trans 11, 2038-2046.
28. 2+ (pmip = 2-(2'-pyrimidyl) imidazo[4,5-f][1,10]phenanthroline. Polyhedron 28,1355-1361.
29. Spector D.L., Goldman, R.D., and Leinwand, L.A., eds. (1998). Cells: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, New York), Vol. 1, Chapter 15.
30. Steck, E.A., and Day, A.R. (1943). Reactions of phenanthraquinone and retenequinone with aldehydes and ammonium acetate in acetic acid solution. J Am Chem Soc 65, 452-456.
31. Sullivan, B.P., Sullivan, D.J., and Meyer, T.J. (1978). Mixed phosphine 2,2'-bipyridine complexes of ruthenium. Inorg Chem 17, 3334-3341.
32. Sun, J., Wu, S., Han, Y., Liu, J., Ji, L.N., and Mao, Z.W. (2008). Synthesis, crystal structure and DNA-binding studies of a Ru(II) complex containing two main ligands. Inorg Chem Commun 11, 1382-1384.
33. Sundquist, W.I., and Lippard, S.J. (1990). The coordination chemistry of platinum anticancer drugs and related compounds with DNA. Coord Chem Rev 100, 293-322.
34. Tan, C.P., Liu, J., Li, H., Zheng, W.J., Shi, S., Chen, L.M., and Ji, L.N. (2008). Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes J Inorg Biochem 102, 1644-1653.
35. Waring, M.J. (1965). Complex formation between ethidium bromide and nucleic acids. J Mol Biol 13, 269-282.
36. Wu, J.Z., Li, L., Yang, G., Zeng, T.-X., and Ji, L.N. (1997). Characterization and luminiscent DNA-binding study of a series of ruthenium complexes containing 2-arylimidazo[f] 1,10-phenanthroline. Polyhedron 16, 103-107.
37. Xiong, Y., and Ji, L.N. (1999). Synthesis, DNA-binding and DNA-mediated luminescence quenching of ruthenium(II) polypyridyl complexes. Coord Chem Rev 185/186, 711-733.
38. 2+. J Inorg Biochem 103, 881-890.
39. Zorzet, S., Sorce, A., Casarsa, C., Cocchietto, M., and Sava, G. (2001). Pharmacological effects of the ruthenium complex NAMI-A given orally to CBA mice with MCa mammary carcinoma. Met-Based drugs 8, 1-7.